Skip to main content
. 2020 Jan 8;69(6):1019–1026. doi: 10.1136/gutjnl-2019-319954

Figure 2.

Figure 2

Eradication rates of each therapy groups in the presence of clarithromycin resistance in PP population. CLA, clarithromycin; PP, per protocol; VA-dual, vonoprazan and amoxicillin dual therapy; VAC-triple, vonoprazan, amoxicillin and clarithromycin triple therapy.